This Biotech Just Cleared A Big FDA Hurdle In Its Quest To Improve ADHD Treatment

Benzinga

16 days ago

Dr. Ann Childress and Shane Schaffer, Chairman & CEO of Cingulate, were recently guests on Benzinga's All Access.

Cingulate is a biotechnology company developing drugs for a range of underserved conditions. The company has developed a proprietary technology called Precision Timed Release™ (PTR™). The technology allows a single pill to contain multiple doses of a drug, relieving the pill burden many people with chronic conditions suffer.

Cingulate was just given clearance by the FDA to seek full approval for its lead candidate, CTx-1301.

Recommended

Growing Wildfires Force 30,000 to Evacuate in Northern California as Extreme Temperatures Worsen Conditions

BYD Launches First EV Factory in Southeast Asia, Eyes Regional Expansion

House Democrat Proposes Amendment to Reverse Supreme Court's Immunity Decision, Hold Former Presidents Accountable for Criminal Acts

Texas Federal Court Halts FTC's Ban on Noncompete Agreements

Delta Flight Diverted After Passengers Served Spoiled Food

National Women's Soccer League Allows Private Equity Firms to Take Majority Stake as Attendance Surges

Conservative Leader Predicts 'Second American Revolution,' Which Would Remain 'Bloodless If the Left Allows It to Be'

Tesla's Shanghai Factory Visit by EU Inspectors Could Benefit Export to EU

Bitcoin's Price Plummets to Nearly $54,000 as Mt. Gox Repays Creditors in Crypto

Tesla Showcases Humanoid Robot Optimus at World AI Conference in Shanghai

Tesla's Stock Soars Over 25% After Impressive Vehicle Delivery Numbers, But Analysts Remain Wary of EV Giant's Shifting Corporate Strategy

Tesla's Stock Skyrockets 17% in Two Days After Q2 Delivery Beat, Leaving Short Sellers with $3.5 Billion Loss

Doubts About President Biden's Capacity to Serve Shared Among Houe Democratic Lawmakers

Saks Fifth Avenue Parent HBC to Acquire Neiman Marcus Group in $2.65B Deal To Tackle Shifts in Consumer Spending

Biden Tells Democratic Governors That He Needs More Sleep, Will Stop Scheduling Events Afer 8 PM

Biden Admits He 'Screwed Up' in Debate Performance, Calls it a 'Bad Night'